Overexpression of MZB1 has been reported in patients of leukemia and lymphoma [163], pancreatic cancer [164], lung adenocarcinoma [165,166,167,168], multiple myeloma [169,170], estrogen receptor-positive breast cancer [171], and metastatic cutaneous melanoma [172]. Here, MZB1 is linked to leukemia.